StonvexLoading…
StonvexStonvexStonvexCore line items from DNTH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $2.04M | $6.24M | $2.83M |
Operating Income | $-177.93M | $-101.86M | $-48.17M |
Net Income | $-162.34M | $-84.97M | $-43.55M |
EPS (Diluted) | $-4.20 | $-2.55 | $-8.45 |
Total Assets | $530.92M | $374.01M | $179.41M |
Total Liabilities | $37.52M | $21.53M | $10.54M |
Cash & Equivalents | $51.09M | $22.79M | $132.32M |
Free Cash Flow OCF − CapEx | $-129.27M | $-78.28M | $-36.97M |
Shares Outstanding | 43.22M | 31.12M | 14.82M |